CVS Health Corp.’s announcement Monday that former Aetna Inc. Chief Executive Mark Bertolini will leave the CVS board exposed tensions underlying one of the biggest U.S. health-care mergers. Mr. Bertolini joined the board after the pharmacy operator paid nearly $70 billion to buy the health insurer in 2018.
Trending:
CVS sloughs off key player in Aetna deal